An Improved Animal Model of Multiple Myeloma Bone Disease

Multiple myeloma (MM) is a plasma cell malignancy that causes an accumulation of terminally differentiated monoclonal plasma cells in the bone marrow, accompanied by multiple myeloma bone disease (MMBD). MM animal models have been developed and enable to interrogate the mechanism of MM tumorigenesis...

Full description

Bibliographic Details
Main Authors: Syed Hassan Mehdi, Carol A Morris, Jung Ae Lee, Donghoon Yoon
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/17/4277
_version_ 1797521568911327232
author Syed Hassan Mehdi
Carol A Morris
Jung Ae Lee
Donghoon Yoon
author_facet Syed Hassan Mehdi
Carol A Morris
Jung Ae Lee
Donghoon Yoon
author_sort Syed Hassan Mehdi
collection DOAJ
description Multiple myeloma (MM) is a plasma cell malignancy that causes an accumulation of terminally differentiated monoclonal plasma cells in the bone marrow, accompanied by multiple myeloma bone disease (MMBD). MM animal models have been developed and enable to interrogate the mechanism of MM tumorigenesis. However, these models demonstrate little or no evidence of MMBD. We try to establish the MMBD model with severe bone lesions and easily accessible MM progression. 1 × 10<sup>6</sup> luciferase-expressing 5TGM1 cells were injected into 8–12 week-old NOD SCID gamma mouse (NSG) and C57BL/KaLwRij mouse via the tail vein. Myeloma progression was assessed weekly via in vivo bioluminescence (BL) imaging using IVIS-200. The spine and femur/tibia were extracted and scanned by the micro-computer tomography for bone histo-morphometric analyses at the postmortem. The median survivals were 56 days in NSG while 44.5 days in C57BL/KaLwRij agreed with the BL imaging results. Histomorphic and DEXA analyses demonstrated that NSG mice have severe bone resorption that occurred at the lumbar spine but no significance at the femur compared to C57BL/KaLwRij mice. Based on these, we conclude that the systemic 5TGM1 injected NSG mouse slowly progresses myeloma and develops more severe MMBD than the C57BL/KaLwRij model.
first_indexed 2024-03-10T08:14:21Z
format Article
id doaj.art-24f7bec2b74e4803b06d42262f9cfa30
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T08:14:21Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-24f7bec2b74e4803b06d42262f9cfa302023-11-22T10:24:55ZengMDPI AGCancers2072-66942021-08-011317427710.3390/cancers13174277An Improved Animal Model of Multiple Myeloma Bone DiseaseSyed Hassan Mehdi0Carol A Morris1Jung Ae Lee2Donghoon Yoon3Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USAGraduate Program in Interdisciplinary Biomedical Sciences, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADepartment of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA 01605, USAMyeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USAMultiple myeloma (MM) is a plasma cell malignancy that causes an accumulation of terminally differentiated monoclonal plasma cells in the bone marrow, accompanied by multiple myeloma bone disease (MMBD). MM animal models have been developed and enable to interrogate the mechanism of MM tumorigenesis. However, these models demonstrate little or no evidence of MMBD. We try to establish the MMBD model with severe bone lesions and easily accessible MM progression. 1 × 10<sup>6</sup> luciferase-expressing 5TGM1 cells were injected into 8–12 week-old NOD SCID gamma mouse (NSG) and C57BL/KaLwRij mouse via the tail vein. Myeloma progression was assessed weekly via in vivo bioluminescence (BL) imaging using IVIS-200. The spine and femur/tibia were extracted and scanned by the micro-computer tomography for bone histo-morphometric analyses at the postmortem. The median survivals were 56 days in NSG while 44.5 days in C57BL/KaLwRij agreed with the BL imaging results. Histomorphic and DEXA analyses demonstrated that NSG mice have severe bone resorption that occurred at the lumbar spine but no significance at the femur compared to C57BL/KaLwRij mice. Based on these, we conclude that the systemic 5TGM1 injected NSG mouse slowly progresses myeloma and develops more severe MMBD than the C57BL/KaLwRij model.https://www.mdpi.com/2072-6694/13/17/4277murine modelmultiple myeloma bone diseasesevere osteolytic lesions
spellingShingle Syed Hassan Mehdi
Carol A Morris
Jung Ae Lee
Donghoon Yoon
An Improved Animal Model of Multiple Myeloma Bone Disease
Cancers
murine model
multiple myeloma bone disease
severe osteolytic lesions
title An Improved Animal Model of Multiple Myeloma Bone Disease
title_full An Improved Animal Model of Multiple Myeloma Bone Disease
title_fullStr An Improved Animal Model of Multiple Myeloma Bone Disease
title_full_unstemmed An Improved Animal Model of Multiple Myeloma Bone Disease
title_short An Improved Animal Model of Multiple Myeloma Bone Disease
title_sort improved animal model of multiple myeloma bone disease
topic murine model
multiple myeloma bone disease
severe osteolytic lesions
url https://www.mdpi.com/2072-6694/13/17/4277
work_keys_str_mv AT syedhassanmehdi animprovedanimalmodelofmultiplemyelomabonedisease
AT carolamorris animprovedanimalmodelofmultiplemyelomabonedisease
AT jungaelee animprovedanimalmodelofmultiplemyelomabonedisease
AT donghoonyoon animprovedanimalmodelofmultiplemyelomabonedisease
AT syedhassanmehdi improvedanimalmodelofmultiplemyelomabonedisease
AT carolamorris improvedanimalmodelofmultiplemyelomabonedisease
AT jungaelee improvedanimalmodelofmultiplemyelomabonedisease
AT donghoonyoon improvedanimalmodelofmultiplemyelomabonedisease